Carriage studies - what do they add? Human bacterial challenge experiments as an alternative
Pandemic influenza A (2009) Clinical Controversies in Clinical Care: What worked and what did not David SC Hui MBBS, MD(UNSW), FRACP, FRCP, FCCP, FHKCP,
Contact Evaluation Your name Institution/organization Meeting Date International Standard 16.
Contact Evaluation Your name Institution/organization Meeting Date International Standards 18, 19.
World Health Day 2011. 2 No action today, no cure tomorrow 7 April 2011 | World Health Day Why AMR is a global concern? Antimicrobial resistance (AMR)
The legal ecology of resistance: why normal IP rules should be adjusted for antibiotics Kevin Outterson [email protected] Oxford 25 April 2014.
Interferon-free HCV Therapy for Those with HIV: Ready for Prime Time?
09.00 09.30 mark rupp - publiceren
One Health Model
Levy
No One Left Behind: HIV and Tuberculosis co-infection Thank you to my co-authors Mark Harrington Soumya Swaminathan Haileyesus Getahun Diane Havlir, University.
Engaging health care providers in ARV based prevention Edwina Wright MD PhD Alfred Hospital, Monash University The Burnet Institute World AIDS Conference,
